Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists
Previous Article
ChatGPT... yap uoy sselnu tnadnuder eruta
Next Article
P160... nolos-MBD yb dleh sdnuf ’RLF‘